INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:INSP • US4577301090

65.7 USD
+0.1 (+0.15%)
At close: Feb 6, 2026
66.65 USD
+0.95 (+1.45%)
After Hours: 2/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to INSP. INSP was compared to 186 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • INSP had positive earnings in the past year.
  • INSP had a positive operating cash flow in the past year.
  • In the past 5 years INSP reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: INSP reported negative operating cash flow in multiple years.
INSP Yearly Net Income VS EBIT VS OCF VS FCFINSP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • INSP has a Return On Assets of 5.52%. This is amongst the best in the industry. INSP outperforms 82.80% of its industry peers.
  • INSP has a better Return On Equity (6.69%) than 81.72% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.82%, INSP is in the better half of the industry, outperforming 75.81% of the companies in the same industry.
Industry RankSector Rank
ROA 5.52%
ROE 6.69%
ROIC 4.82%
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
INSP Yearly ROA, ROE, ROICINSP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

  • With a decent Profit Margin value of 5.05%, INSP is doing good in the industry, outperforming 77.96% of the companies in the same industry.
  • With a decent Operating Margin value of 4.16%, INSP is doing good in the industry, outperforming 68.82% of the companies in the same industry.
  • With an excellent Gross Margin value of 84.92%, INSP belongs to the best of the industry, outperforming 94.62% of the companies in the same industry.
  • INSP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.16%
PM (TTM) 5.05%
GM 84.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
INSP Yearly Profit, Operating, Gross MarginsINSP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INSP is destroying value.
  • Compared to 1 year ago, INSP has more shares outstanding
  • Compared to 5 years ago, INSP has more shares outstanding
  • INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INSP Yearly Shares OutstandingINSP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
INSP Yearly Total Debt VS Total AssetsINSP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 9.57 indicates that INSP is not in any danger for bankruptcy at the moment.
  • INSP's Altman-Z score of 9.57 is amongst the best of the industry. INSP outperforms 88.71% of its industry peers.
  • There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.57
ROIC/WACC0.48
WACC10.08%
INSP Yearly LT Debt VS Equity VS FCFINSP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • INSP has a Current Ratio of 5.29. This indicates that INSP is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 5.29, INSP belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
  • A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
  • The Quick ratio of INSP (4.01) is better than 75.81% of its industry peers.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 4.01
INSP Yearly Current Assets VS Current LiabilitesINSP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 90.65% over the past year.
  • The Revenue has grown by 16.81% in the past year. This is quite good.
  • The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.80% on average over the next years. This is quite good.
  • INSP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.14% yearly.
EPS Next Y-14.92%
EPS Next 2Y0.95%
EPS Next 3Y14.05%
EPS Next 5Y18.8%
Revenue Next Year13.53%
Revenue Next 2Y12.1%
Revenue Next 3Y11.94%
Revenue Next 5Y11.14%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
INSP Yearly Revenue VS EstimatesINSP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
INSP Yearly EPS VS EstimatesINSP Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • INSP is valuated quite expensively with a Price/Earnings ratio of 32.21.
  • Compared to the rest of the industry, the Price/Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 73.12% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.93. INSP is around the same levels.
  • The Price/Forward Earnings ratio is 37.27, which means the current valuation is very expensive for INSP.
  • 70.43% of the companies in the same industry are more expensive than INSP, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of INSP to the average of the S&P500 Index (27.77), we can say INSP is valued slightly more expensively.
Industry RankSector Rank
PE 32.21
Fwd PE 37.27
INSP Price Earnings VS Forward Price EarningsINSP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • INSP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. INSP is cheaper than 71.51% of the companies in the same industry.
  • INSP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INSP is cheaper than 89.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.32
EV/EBITDA 27.91
INSP Per share dataINSP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • INSP's earnings are expected to grow with 14.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.95%
EPS Next 3Y14.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for INSP!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INSPIRE MEDICAL SYSTEMS INC

NYSE:INSP (2/6/2026, 8:04:00 PM)

After market: 66.65 +0.95 (+1.45%)

65.7

+0.1 (+0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12
Earnings (Next)02-11
Inst Owners111.59%
Inst Owner Change-0.27%
Ins Owners0.74%
Ins Owner Change0.1%
Market Cap1.91B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts80
Price Target131.09 (99.53%)
Short Float %10.28%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)-9.17%
PT rev (3m)3.12%
EPS NQ rev (1m)31.97%
EPS NQ rev (3m)30.73%
EPS NY rev (1m)39.14%
EPS NY rev (3m)185.48%
Revenue NQ rev (1m)0.98%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.44%
Valuation
Industry RankSector Rank
PE 32.21
Fwd PE 37.27
P/S 2.16
P/FCF 19.32
P/OCF 14.28
P/B 2.86
P/tB 2.86
EV/EBITDA 27.91
EPS(TTM)2.04
EY3.11%
EPS(NY)1.76
Fwd EY2.68%
FCF(TTM)3.4
FCFY5.18%
OCF(TTM)4.6
OCFY7%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
Industry RankSector Rank
ROA 5.52%
ROE 6.69%
ROCE 5.27%
ROIC 4.82%
ROICexc 8.98%
ROICexgc 8.98%
OM 4.16%
PM (TTM) 5.05%
GM 84.92%
FCFM 11.2%
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 276.46%
Cap/Sales 3.95%
Interest Coverage 250
Cash Conversion 270.95%
Profit Quality 221.78%
Current Ratio 5.29
Quick Ratio 4.01
Altman-Z 9.57
F-Score8
WACC10.08%
ROIC/WACC0.48
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-14.92%
EPS Next 2Y0.95%
EPS Next 3Y14.05%
EPS Next 5Y18.8%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.53%
Revenue Next 2Y12.1%
Revenue Next 3Y11.94%
Revenue Next 5Y11.14%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year658.15%
EBIT Next 3Y123.39%
EBIT Next 5Y70.56%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A

INSPIRE MEDICAL SYSTEMS INC / INSP FAQ

What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

ChartMill assigns a fundamental rating of 6 / 10 to INSP.


Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?

ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.


How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.


What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 32.21 and the Price/Book (PB) ratio is 2.86.


What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?

The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.